What Are Research Peptides? A Primer for Laboratory Scientists

The dominant manufacturing method for research peptides is Fmoc-based solid-phase peptide synthesis, first described by Merrifield in 1963. In this process, amino acids are sequentially coupled to a resin-bound growing chain, with each residue protected by a fluorenylmethyloxycarbonyl (Fmoc) group that is removed before the next coupling step.

After chain assembly, the peptide is cleaved from the resin and global protecting groups are removed using trifluoroacetic acid (TFA). The crude product is then purified — typically by preparative reverse-phase HPLC — to achieve the purity specifications required for research use.

Purity is the single most critical quality attribute for research peptides. Impurities — including deletion sequences, oxidized residues, and TFA adducts — can confound experimental results by producing off-target biological activity or attenuating the signal of the target compound.

The industry standard for research-grade peptides is ≥98% purity by reverse-phase HPLC (RP-HPLC), measured as area-under-curve at 214 nm or 220 nm. Premium suppliers targeting preclinical research routinely achieve ≥99% purity. Mass spectrometry (ESI-MS or MALDI-TOF) is used to confirm molecular identity by verifying the observed mass against the theoretical monoisotopic mass.

Research peptides are supplied in lyophilized (freeze-dried) form to maximize stability during shipping and long-term storage. Lyophilization removes water under vacuum at low temperature, yielding a dry powder or cake that is far more stable than aqueous solution.

Most lyophilized peptides are stable for 24–36 months when stored at −20 °C in a desiccated, light-protected environment. Repeated freeze-thaw cycles degrade peptide integrity; researchers should aliquot reconstituted stock solutions into single-use volumes before freezing.

Solvent selection for reconstitution depends on the peptide's physicochemical properties. Hydrophilic peptides typically dissolve readily in sterile water or phosphate-buffered saline (PBS). Hydrophobic peptides may require initial dissolution in a small volume of organic co-solvent (DMSO, acetonitrile, or dilute acetic acid) before aqueous dilution.

Bacteriostatic water (0.9% benzyl alcohol) is the preferred reconstitution vehicle for peptides intended for multi-dose in vivo research use, as the preservative prevents microbial growth between uses. Researchers should always consult the peptide's solubility data sheet and avoid vortexing, which can cause aggregation; gentle swirling or sonication is preferred.